• Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
  
• Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
  

PubMed=2598402; DOI=10.1007/BF00692343
Moulay Abdellah Alaoui-Jamali, Ming-Biao Yin, Alessandra Mazzoni, Issam Bankusli, Youcef M. Rustum;
Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.
Cancer Chemother. Pharmacol. 25:77-83(1989)

PubMed=2751261
Alessandra Mazzoni, Fabio Trave, Gianfranco Canti, Paola Franco;
Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells.
Anticancer Res. 9:367-371(1989)

PubMed=8012063
Guido Cimoli, Monica Valenti, Silvio Parodi, Alessandra Mazzoni, Fabio De Sessa, PierFranco Conte, Patrizia Russo;
Reversal of 'atypical'-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Oncol. Res. 5:311-323(1993)

PubMed=7713987; DOI=10.1007/BF01198097
Guido Cimoli, Monica Valenti, Elvira Noviello, Silvio Parodi, Alessandra Mazzoni, Elisabetta Rovini, Fabio De Sessa, Patrizia Russo;
'Atypical' multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3).
J. Cancer Res. Clin. Oncol. 121:155-163(1995)